Roche wins EU panel's recommendation for hemophilia drug

ZURICH (Reuters) - A European Union panel on Friday recommended approval of Roche's Hemlibra to treat hemophilia in some patients after the Swiss drugmaker got the green light last year to begin selling the medicine in the United States.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news